De Greef Roderick's Form 4/A amendment
AmendedBiolife Solutions Inc (BLFS) · filed Jan 24, 2023
- Accession no.
- 0001437749-23-001698
- Filed
- Jan 24, 2023
- Trade date
- Jan 19, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Jan 20, 2023
This filing lists 1 non-derivative transaction. Open-market sales total $88.1K. It was filed 5 days after the trade.
This amendment replaces 0001437749-23-001486 (filed Jan 20, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| De Greef RoderickCIK 0001241181 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 19, 2023 | Common Stock | SSaleDisposed | −3,801 | $23.19 | −$88,145.19 | 40,160 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The sale reported herein was made to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.